Yousufuddin Mohammed, Mahmood Maryam, Barkoudah Ebrahim, Badr Fatimazahra, Khandelwal Kanika, Manyara Warren, Sharma Umesh, Abdalrhim Ahmed D, Issa Meltiady, Bhagra Sumit, Murad Mohammad H
Department of Hospital Internal Medicine, Mayo Clinic Health System, Austin, Minnesota, USA.
Division of Public Health, Infectious Diseases, and Occupational Medicine, Mayo Clinic, Rochester, Minnesota, USA.
Open Forum Infect Dis. 2024 Apr 5;11(5):ofae197. doi: 10.1093/ofid/ofae197. eCollection 2024 May.
We compared long-term mortality and readmission rates after COVID-19 hospitalization based on rural-urban status and assessed the impact of COVID-19 vaccination introduction on clinical outcomes by rurality.
The study comprised adults hospitalized for COVID-19 at 17 hospitals in 4 US states between March 2020 and July 2022, followed until May 2023. The main analysis included all patients, whereas a sensitivity analysis focused on residents from 4 states containing 17 hospitals. Additional analyses compared the pre- and postvaccination periods.
The main analysis involved 9325 COVID-19 hospitalized patients: 31% were from 187 rural counties in 31 states; 69% from 234 urban counties in 44 states; the mean age was 65 years (rural, 66 years; urban, 64 years); 3894 women (rural, 41%; urban, 42%); 8007 Whites (rural, 87%; urban, 83%); 1738 deaths (rural, 21%; urban, 17%); and 2729 readmissions (rural, 30%; urban, 29%). During a median follow-up of 602 days, rural residence was associated with a 22% higher all-cause mortality (log-rank, < .001; hazard ratio, 1.22; 95% confidence interval, 1.10-1.34, < .001), and a trend toward a higher readmission rate (log-rank, = .038; hazard ratio, 1.06; 95% confidence interval, .98-1.15; = .130). The results remained consistent in the sensitivity analysis and in both pre- and postvaccination time periods.
Patients from rural counties experienced higher mortality and tended to be readmitted more frequently following COVID-19 hospitalization over the long term compared with those from urban counties, a difference that remained even after the introduction of COVID-19 vaccines.
我们比较了基于城乡状况的新冠病毒疾病(COVID-19)住院后的长期死亡率和再入院率,并评估了按农村地区划分的COVID-19疫苗接种对临床结局的影响。
该研究纳入了2020年3月至2022年7月期间在美国4个州的17家医院因COVID-19住院的成年人,随访至2023年5月。主要分析包括所有患者,而敏感性分析聚焦于来自包含这17家医院的4个州的居民。额外分析比较了疫苗接种前后的时期。
主要分析涉及9325名COVID-19住院患者:31%来自31个州的187个农村县;69%来自44个州的234个城市县;平均年龄为65岁(农村66岁;城市64岁);3894名女性(农村41%;城市42%);8007名白人(农村87%;城市83%);1738例死亡(农村21%;城市17%);2729例再入院(农村30%;城市29%)。在中位随访602天期间,农村居住与全因死亡率高22%相关(对数秩检验,P<0.001;风险比,1.22;95%置信区间,1.10 - 1.34,P<0.001),且再入院率有升高趋势(对数秩检验,P = 0.038;风险比,1.06;95%置信区间,0.98 - 1.15;P = 0.130)。在敏感性分析以及疫苗接种前后两个时期,结果均保持一致。
与城市县的患者相比,农村县的患者在COVID-19住院后长期死亡率更高,且再入院倾向更频繁,即使在引入COVID-19疫苗后这种差异依然存在。